Zevra Therapeutics (ZVRA) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

ZVRA Zevra Therapeutics

Watchlist

8.600
-0.020-0.23%

Close Nov 18 16:00 ET

459.03MMarket Cap-4037P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Analysts Have Made A Financial Statement On Zevra Therapeutics, Inc.'s (NASDAQ:ZVRA) Third-Quarter Report
Yahoo FinanceNov 16 07:43 ET
Maxim Group Maintains Zevra Therapeutics(ZVRA.US) With Buy Rating, Maintains Target Price $25
Moomoo NewsNov 15 10:31 ET · Ratings
Zevra Therapeutics: Strong Financials, Strategic FDA Approval, and Growth Prospects Drive Buy Rating
TipRanksNov 15 10:15 ET · Ratings
Zevra Therapeutics Is Maintained at Buy by Canaccord Genuity
Dow JonesNov 14 11:27 ET · Ratings
Zevra Therapeutics Analyst Ratings
BenzingaNov 14 11:15 ET · Ratings
US$20.14 - That's What Analysts Think Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Is Worth After These Results
Simply Wall StNov 14 07:38 ET

Comments

Stock_Drift

Nov 11 15:42

$Zevra Therapeutics (ZVRA.US)$

Jaguar8

Nov 11 15:37

NEWS

$Zevra Therapeutics (ZVRA.US)$
Zevra Therapeutics to Present Data Demonstrating Relevance of Swallow Domain in Niemann-Pick Disease Type C Clinical Severity Scale at 53rd Child Neurology Society Annual Meeting
Zevra Therapeutics (NASDAQ: ZVRA) announced the presentation of data validating the swallow domain's significance in the Niemann-Pick Disease Type C Clinical Severity Scale(NPCCSS) at the 53rd Child Neurology Society Annual Meeting. The study, presented by Dr. Elizabeth Berry-Kravis, in...

Meltyy

Sep 25 06:31

See FDA PDUFA update 👀 👇

🚨 This Week’s PDUFAs:
$Heron Therapeutics (HRTX.US)$ : 🤔
⇨ ZYNRELEF® Vial Access Needle
‣ Postoperative pain
‣ PDUFA: 9/23/24 (sNDA)
$Bristol-Myers Squibb (BMY.US)$ : 🤔
⇨ KarXT (xanomeline-trospium)
‣ Schizophrenia
‣ PDUFA: 9/26/24 (NDA)
$Sanofi (SNY.US)$ $Regeneron Pharmaceuticals (REGN.US)$ : 🤔
⇨ Dupixent
‣ Chronic obstructive pulmonary disease
‣ PDUFA: 9/27/24 (sBLA)
$BeiGene (BGNE.US)$ $Merck & Co (MRK.US)$ & $Bristol-Myers Squibb (BMY.US)$ : 🤔
⇨ Tislelizumab, KEYTRUDA, OPDIVO & YER...

Jaguar8

Sep 24 06:55

NEWS

$Zevra Therapeutics (ZVRA.US)$
Zevra Therapeutics to Present Top-Line Data from the Phase 2 Clinical Trial of KP1077 for Idiopathic Hypersomnia at Sleep Europe 2024
Zevra Therapeutics (NASDAQ: ZVRA) announced that top-line data from its Phase 2 clinical trial of KP1077 for idiopathic hypersomnia (IH) will be presented at Sleep Europe 2024. The trial (NCT05668754) was a placebo-controlled, double-blind, randomized withdrawal study evaluating the safety and tolerability of KP1077 (serdexmethylp...